Cargando…
Increased therapeutic efficiency of a lipid-soluble alkylating agent incorporated in liposomes.
A highly hydrophobic alkylating agent, 1-N,N-bis(beta-bromoethyl) amino-3-methylnaphthalene, given as the free drug in oil, cured a substantial proportion of mice bearing the PC6 myeloma in the dose range 2-7 mg/kg. However, these doses were toxic, and the LD50 was 6-7 mg/kg. When incorporated in li...
Autores principales: | Babbage, J. W., Berenbaum, M. C. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1982
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2011043/ https://www.ncbi.nlm.nih.gov/pubmed/7093119 |
Ejemplares similares
-
Gadolinium(III) Complexes with N-Alkyl-N-methylglucamine Surfactants Incorporated into Liposomes as Potential MRI Contrast Agents
por: Silva, Simone Rodrigues, et al.
Publicado: (2015) -
Stability of Alkyl Chain-Mediated Lipid Anchoring in Liposomal Membranes
por: Gleue, Lukas, et al.
Publicado: (2020) -
Dose-response curves for agents that impair cell reproductive integrity. A fundamental difference between dose-response curves of antimetabolites and those for radiation and alkylating agents.
por: Berenbaum, M. C.
Publicado: (1969) -
Improving the therapeutic index of two alkylating agents.
por: Millar, J. L., et al.
Publicado: (1980) -
Incorporation of paramagnetic, fluorescent and PET/SPECT contrast agents into liposomes for multimodal imaging
por: Mitchell, Nick, et al.
Publicado: (2013)